• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

GSK2983559 free acid

CAS No. 1579965-12-0

GSK2983559 free acid ( —— )

产品货号. M26238 CAS No. 1579965-12-0

GSK2983559 free acid is an effective and selective inhibitor of receptor-interacting protein 2 (RIP2).

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥786 有现货
10MG ¥1215 有现货
25MG ¥2033 有现货
50MG ¥3038 有现货
100MG ¥4560 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    GSK2983559 free acid
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    GSK2983559 free acid is an effective and selective inhibitor of receptor-interacting protein 2 (RIP2).
  • 产品描述
    GSK2983559 free acid is an effective and selective inhibitor of receptor-interacting protein 2 (RIP2). GSK2983559 free acid shows excellent activity in blocking many proinflammatory cytokine responses in human inflammatory bowel disease explant samples.
  • 同义词
    ——
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    leucyl-tRNA synthetase; Ras-related GTP-binding protein D (RagD)
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    1579965-12-0
  • 分子量
    538.5
  • 分子式
    C21H23N4O7PS2
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCOP(O)(O)=O
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Jong Hyun Kim, et al. Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction. Nat Commun. 2017 Sep 29;8(1):732.
产品手册
关联产品
  • Biotin-PEG2-C2-iodoa...

    Biotin-PEG2-C2-iodoacetamide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • Methyl nomilinate

    Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.

  • Cyclic MKEY

    MKEY, a synthetic cyclic peptide inhibitor of CXCL4-CCL5 heterodimer formation, has been shown to protect against atherosclerosis and aortic aneurysm formation by mediating inflammation, but whether it modulates neuroinflammation and brain injury has not been studied.